Skip to content

Observation of the efficacy of repetitive transcranial magnetic stimulation combined with extracorporeal diaphragmatic pacemaker on swallowing disorders in Parkinson's disease

Observation of the efficacy of repetitive transcranial magnetic stimulation combined with extracorporeal diaphragmatic pacemaker on swallowing disorders in Parkinson's disease

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122628
Enrollment
Unknown
Registered
2026-04-15
Start date
2025-04-17
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough and swallowing disorders after Parkinson's disease

Interventions

Experimental group :Conventional swallowing function training,rTMS,Extracorporeal diaphragmatic pacemaker treatment
Control group :Conventional swallowing function training,Extracorporeal diaphragmatic pacemaker treatment

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Age 38-85 years old; 2.All met the diagnostic criteria for primary Parkinson's disease formulated by the Parkinson's Disease and Movement Disorders Group of the Neurology Branch of the Chinese Medical Association in 2016, and were diagnosed after differential diagnosis by CT or MRI, with Hoehn Yahr stage 2-4; 3.Swallowing disorders are confirmed by FESS examination; 4.Cough dysfunction assessed by cough function assessment; 5.All subjects signed a written informed consent form;

Exclusion criteria

Exclusion criteria: 1. History of using sedatives, antidepressants, or other drugs that may alter cortical excitability; 2. Intracranial metal implants, pacemaker, skull defects, history of epilepsy, or other contraindications unsuitable for transcranial magnetic stimulation treatment; 3. Chronic respiratory diseases or history of such diseases (e.g., chronic obstructive pulmonary disease, asthma, emphysema); 4. History of upper respiratory tract infection within the past 4 weeks; 5. Unstable patient condition, presence of contraindications to rehabilitation training.

Design outcomes

Primary

MeasureTime frame
Cough reflex threshold;Peak Expiratory Flow Rate,PEFR;Rosenbek penetration aspiration scale, PAS;;

Secondary

MeasureTime frame
Swallowing-specific Quality of Life Scale (SWAL-QOL);Functional near-infrared spectroscopy imaging data analysis;

Countries

China

Contacts

Public ContactDong Xiaojin

Beijing Haidian Hospital

18612401979@163.com+86 10 82693141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026